5th Feb 2015 08:17
LONDON (Alliance News) - Premaitha Health PLC shares rose early Thursday after the company said it has been awarded a CE mark for its IONA test.
The CE mark means the IONA in-vitro test has met the quality standards in the European Commission's In Vitro Diagnostic Medical Device Directive. Premaitha said it is the only company authorised in Europe to sell a product to allow a laboratory to offer one of its services.
"The launch of the IONA test is a huge milestone for Premaitha. We are the first company to offer a CE-marked NIPT product in an area where the current standard of prenatal testing is simply inadequate and there is a huge unmet need," said Premaitha Chief Executive Stephen Little.
Premaitha shares were up 9.1% to 24.01 pence on Thursday, one of the best performers in the AIM All-Share index.
By Sam Unsted; [email protected]; @SamUAtAlliance
Copyright 2015 Alliance News Limited. All Rights Reserved.
Related Shares:
Premaitha Health